Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002256
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Dideoxycytidine Ro 24-2027 A Treatment Protocol for the Use of Dideoxycytidine ddC in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine AZT Therapy
Sponsor:
Hoffmann-La Roche
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Dideoxycytidine Ro 24-2027 A Treatment Protocol for the Use of Dideoxycytidine ddC in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine AZT Therapy
Status:
COMPLETED
Status Verified Date:
1994-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To provide zalcitabine ddC for patients with AIDS or Advanced ARC in whom zidovudine AZT is contraindicated or who have failed treatment with or are intolerant to AZT and to demonstrate that ddC monotherapy is safe and tolerable in this patient population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| N3663 | None | None | None |